n/a 0.0 0.0%
Last Trade -
| Market Cap | ÂŁn/a |
| Enterprise Value | ÂŁn/a |
| Revenue | ÂŁ3.46m |
| Position in Universe | th / 6651 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008E | 2009E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 1.91 | 2.67 | 4.78 | +58.2% | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
BioTrove, Inc. develops, manufactures and markets instruments and consumables for genomic analysis, high-throughput screening and molecular diagnostics. The Company’s two marketed systems include OpenArray and RapidFire. Using micro- and nano-fluidic technologies, its products increase the speed exponentially, and decrease the cost of detecting and measuring deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), the genomic materials that store and transmit genetic information inside cells, as well as chemical compounds and proteins. Using its OpenArray or RapidFire systems, customers can design and conduct experiments of a scale and scope, which will provide benefits for the discovery, validation and commercialization processes. In December 2009, Life Technologies Corporation completed the acquisition of BioTrove, Inc.
| Last Annual | December 31st, 2007 |
| Last Interim | January 1st, 1970 |
| Incorporated | February 14, 2000 |
| No. of Shareholders: | 56 |
| No. of Employees: | 70 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | NASDAQ Global Market (Dual Listing) |
| Shares in Issue | 2,310,017 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 12 Gill St Ste 4000, WOBURN, 01801-1743, United States |
| Web | http://www.biotrove.com/ |
| Phone | +1 781 7213600 |
| Contact | () |
| Auditors | KPMG LLP |
As of , shares in Biotrove Inc are trading at n/a, giving the company a market capitalisation of ÂŁn/a. This share price information is delayed by 15 minutes.
Shares in Biotrove Inc are currently trading at n/a and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biotrove Inc price has moved by % over the past year.
There are no analysts currently covering Biotrove Inc.
It is not known when Biotrove Inc will next release financial results.
Biotrove Inc does not currently pay a dividend.
Biotrove Inc does not currently pay a dividend.
Biotrove Inc does not currently pay a dividend.
To buy shares in Biotrove Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Biotrove Inc are currently trading at n/a, giving the company a market capitalisation of ÂŁn/a.
Here are the trading details for Biotrove Inc:
We were not able to load our ranking data for Biotrove Inc
We were not able to load any forecast data for Biotrove Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biotrove Inc. Over the past six months, the relative strength of its shares against the market has been %. At the current price of n/a, shares in Biotrove Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Biotrove Inc.
Biotrove Inc's management team is headed by:
Here are the top five shareholders of Biotrove Inc based on the size of their shareholding:
